Foresee Pharmaceuticals Co., Ltd. announced the appointment of Susan Shelby as Sr. Vice President of Clinical Development and Program Lead /Sr. Vice President of Global Clinical Operations, Biomedical Systems in place of Yisheng Lee, Chief Medical Officer and Wenjin Yang/Chief Scientific Officer (Co-Acting Head of Clinical Development). The effective date is January 10, 2022.